Following activationin vitro, peripheral blood mononuclear cells (PBMC) express cell-associated interleukin-2 receptors (IL-2R) and also release soluble IL-2R into culture supernatants. The present studies were undertaken to define which normal cells were responsible for the release of soluble IL-2Rin vitro. Both cell-associated and soluble IL-2R were quantitatively measured with a “sandwich” enzyme-linked immunoassay employing two monoclonal antibodies. PBMC were separated into populations of surface immunoglobulin-negative cells (T cells and monocytes) and surface immunoglobulin-positive cells (B cells and monocytes), and the T-cell population was further separated into OKT4-positive (OKT4+) cells and OKT4-negative (OKT4−) cells. Following activation with phytohemagglutinin, pokeweed mitogen, and the monoclonal antibody OKT3, large amounts of soluble IL-2R were released by PBMC, unseparated T cells, OKT4+ T cells, and OKT4− T cells. The population containing B cells and monocytes made small but readily detectable amounts of soluble IL-2R when stimulated with these T-cell mitogens; likely the result of contaminating T cells in the population. However, when highly purified B cells were stimulated withStaphylococcus aureus Cowan and recombinant IL-2, they also released small amounts of soluble IL-2R. The release of soluble IL-2R by T cells appeared monocyte dependent when OKT3, but not phytohemagglutinin, was employed for activation, and monocytes themselves released no detectable IL-2R under the conditions employed. These studies define the cellular requirements for the release of soluble IL-2Rin vitro and demonstrate that such receptors are released by B cells, T cells, and both OKT4+ and OKT4− T-cell subsets.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Cantrell DA, Smith KA: The interleukin-2 T-cell system: A new cell growth model. Science 224:1312–1316, 1984
Leonard WJ, Depper JM, Robb RJ, Waldmann TA, Greene WC: Characterization of the human receptor for T cell growth factor. Proc Natl Acad Sci USA 80:6957–6961, 1983
Tsudo M, Uchiyama T, Uchino H: Expression of Tac antigen on activated normal human B cells. J Exp Med 160:612–617, 1984
Waldmann TA, Goldman CK, Robb RJ, Depper JM, Leonard WJ, Sharrow SO, Bongiovanni KF, Korsmeyer SJ, Greene WC: Expression of interleukin-2 receptors on activated B cells. J Exp Med 160:1450–1466, 1984
Moll H, Emmrich F, Simon MM: Recombinant human interleukin 2 directly provides signals for the proliferation and functional maturation of murine B lymphocytes. Immunobiology 169:447–454, 1985
Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL: Soluble interleukin-2 receptors are released from activated human lymphoid cellsin vitro. J Immunol 135:3172–3177, 1985
Rubin LA, Kurman CC, Fritz ME, Nelson DL: Serum levels of soluble interleukin-2 receptor are elevated in patients with certain lymphoreticular malignancies. Clin Res 33:457A, 1985
Uchiyama T, Broder S, Waldmann TA: A monoclonal antibody reactive with activated and functionally mature human T cells. J Immunol 126:1393–1397, 1981
Rubin LA, Kurman CC, Biddison WE, Goldman ND, Nelson DL: A monoclonal antibody, 7G7/B6, that binds to an epitope on the human IL-2 receptor distinct from that recognized by IL-2 or anti-Tac. Hybridoma 4:91–102, 1985
Shaw S, Nelson DL, Shearer GM: Human cytotoxic responsein vitro to trinitrophenyl-modified autologous cells. I. T-cell recognition of TNP in association with widely shared antigens. J Immunol 121:281–289, 1978
Nelson DL, Bundy BM, Pitchon HE, Blaese RM, Strober W: The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependency cellular cytotoxicity. J Immunol 117:1472–1481, 1976
Uchiyama T, Nelson DL, Fleisher TA, Waldmann TA: A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol 26:1398–1403, 1981
Kirchner H, Tosato G, Blaese RM, Broder S, Magrath, IT: Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virusin vitro. J Immunol 122:1310–1313, 1979
Chien MM, Ashman RF: Rapid separation of human monocytes and lymphocytes by Sephadex G-10. J Immunol Methods 71:25–36, 1984
Yarchoan R, Barrow LA, Kurman CC, Strober W, Nelson DL: Human peripheral blood mononuclear cells produce IgA antiinfluenza virus antibody in a secondaryin vitro antibody response. J Immunol 135:1033–1039, 1985
Bundy BM: Studies of the Requirement for Adherent Cells as Accessory Cells in the Specific Cytotoxic Response of the Human Mixed Lymphocytes Culture PhD thesis. Washington, DC, George Washington University, 1982
Herrmann F, Cannistra SA, Levine H, Griffin JD: Expression of IL-2 receptors and binding of IL-2 by gamma-interferon induced human leukemic and normal monocytic cells. J Exp Med 162:1111–1114, 1985
About this article
Cite this article
Nelson, D.L., Rubin, L.A., Kurman, C.C. et al. An analysis of the cellular requirements for the production of soluble interleukin-2 receptorsin vitro . J Clin Immunol 6, 114–120 (1986). https://doi.org/10.1007/BF00918743
- interleukin-2 receptor
- lymphocyte subsets
- lymphocyte activation